Enanta Pharmaceuticals Inc (ENTA)
Insider transactions
A complete record of Form 4 filings tracking every share acquisition and disposal by executives, directors, and senior officers. Filterable by date range and transaction type, the table exposes the direct market actions of those with the deepest knowledge of a company's operations — providing a factual, data-driven signal of internal conviction that complements traditional fundamental and technical analysis.
Transaction date | Executive | Executive Title | Security Type | Acquisition / Disposal | Shares | Share price |
|---|---|---|---|---|---|---|
| Aug 8, 2026 | ROTTINGHAUS, SCOTT T. | Chief Medical Officer | Common Stock | Disposal | 1,467 | 13.34 |
| Mar 11, 2026 | HATA, YUJIRO S | Director | Stock Option (right to buy) | Acquisition | 20,000 | 0 |
| Mar 11, 2026 | RUSSELL, LESLEY | Director | Stock Option (right to buy) | Acquisition | 20,000 | 0 |
| Mar 11, 2026 | PETERSON, KRISTINE | Director | Stock Option (right to buy) | Acquisition | 20,000 | 0 |
| Mar 11, 2026 | VANCE, TERRY | Director | Stock Option (right to buy) | Acquisition | 20,000 | 0 |
| Mar 11, 2026 | CARTER, BRUCE L A | Director | Stock Option (right to buy) | Acquisition | 20,000 | 0 |
| Mar 11, 2026 | FOLETTA, MARK G | Director | Stock Option (right to buy) | Acquisition | 20,000 | 0 |
| Feb 12, 2026 | ROTTINGHAUS, SCOTT T. | Chief Medical Officer | Common Stock | Acquisition | 1,650 | 0 |
| Feb 12, 2026 | ROTTINGHAUS, SCOTT T. | Chief Medical Officer | Common Stock | Acquisition | 5,225 | 0 |
| Feb 12, 2026 | LULY, JAY R. | Director, President and CEO | Common Stock | Acquisition | 15,200 | 0 |
| Feb 12, 2026 | LULY, JAY R. | Director, President and CEO | Common Stock | Acquisition | 4,800 | 0 |
| Feb 12, 2026 | OR, YAT SUN | Chief Scientific Officer | Common Stock | Disposal | 3,413 | 14.25 |
| Feb 12, 2026 | ROTTINGHAUS, SCOTT T. | Chief Medical Officer | Common Stock | Disposal | 3,413 | 14.25 |
| Feb 12, 2026 | LUU, BRENDAN | Chief Business Officer | Common Stock | Acquisition | 4,987 | 0 |
| Feb 12, 2026 | LUU, BRENDAN | Chief Business Officer | Common Stock | Disposal | 3,257 | 14.25 |
| Feb 12, 2026 | KIEFFER, TARA LYNN | Chief Product Strategy Officer | Common Stock | Acquisition | 4,987 | 0 |
| Feb 12, 2026 | LULY, JAY R. | Director, President and CEO | Common Stock | Disposal | 6,155 | 14.25 |
| Feb 12, 2026 | KIEFFER, TARA LYNN | Chief Product Strategy Officer | Common Stock | Disposal | 3,257 | 14.25 |
| Feb 12, 2026 | KOWALSKY, MATTHEW PAUL | Chief Legal Officer | Common Stock | Acquisition | 4,175 | 0 |
| Feb 12, 2026 | KIEFFER, TARA LYNN | Chief Product Strategy Officer | Common Stock | Acquisition | 1,575 | 0 |
| Feb 12, 2026 | KOWALSKY, MATTHEW PAUL | Chief Legal Officer | Common Stock | Acquisition | 1,318 | 0 |
| Feb 12, 2026 | KOWALSKY, MATTHEW PAUL | Chief Legal Officer | Common Stock | Disposal | 1,902 | 14.25 |
| Feb 12, 2026 | LUU, BRENDAN | Chief Business Officer | Common Stock | Acquisition | 1,575 | 0 |
| Feb 12, 2026 | OR, YAT SUN | Chief Scientific Officer | Common Stock | Acquisition | 5,225 | 0 |
| Feb 12, 2026 | OR, YAT SUN | Chief Scientific Officer | Common Stock | Acquisition | 1,650 | 0 |
| Dec 5, 2025 | LULY, JAY R. | Director, President and CEO | Common Stock | Disposal | 4,743 | 14.23 |
| Dec 5, 2025 | TROUT, HARRY R. III | See Remarks | Common Stock | Disposal | 542 | 14.23 |
| Dec 5, 2025 | CAPPS, KATHLEEN S. | See Remarks | Common Stock | Disposal | 323 | 14.23 |
| Dec 5, 2025 | LUU, BRENDAN | Chief Business Officer | Common Stock | Disposal | 1,394 | 14.23 |
| Dec 5, 2025 | OR, YAT SUN | Chief Scientific Officer | Common Stock | Disposal | 2,390 | 14.23 |
| Dec 5, 2025 | ROTTINGHAUS, SCOTT T. | Chief Medical Officer | Common Stock | Disposal | 798 | 14.23 |
| Dec 5, 2025 | KIEFFER, TARA LYNN | Chief Product Strategy Officer | Common Stock | Disposal | 2,106 | 14.23 |
| Dec 2, 2025 | CAPPS, KATHLEEN S. | See Remarks | Common Stock | Disposal | 207 | 13.96 |
| Dec 2, 2025 | TROUT, HARRY R. III | See Remarks | Common Stock | Disposal | 380 | 13.96 |
| Dec 1, 2025 | LULY, JAY R. | Director, President and CEO | Common Stock | Disposal | 1,885 | 14.12 |
| Dec 1, 2025 | CAPPS, KATHLEEN S. | See Remarks | Common Stock | Disposal | 85 | 14.12 |
| Dec 1, 2025 | LUU, BRENDAN | Chief Business Officer | Common Stock | Disposal | 498 | 14.12 |
| Dec 1, 2025 | KIEFFER, TARA LYNN | Chief Product Strategy Officer | Common Stock | Disposal | 753 | 14.12 |
| Dec 1, 2025 | TROUT, HARRY R. III | See Remarks | Common Stock | Disposal | 105 | 14.12 |
| Dec 1, 2025 | OR, YAT SUN | Chief Scientific Officer | Common Stock | Disposal | 753 | 14.12 |
| Nov 25, 2025 | KOWALSKY, MATTHEW PAUL | Chief Legal Officer | Stock Option (right to buy) | Acquisition | 90,000 | 0 |
| Nov 25, 2025 | LUU, BRENDAN | Chief Business Officer | Stock Option (right to buy) | Acquisition | 90,000 | 0 |
| Nov 25, 2025 | LULY, JAY R. | Director, President and CEO | Stock Option (right to buy) | Acquisition | 310,000 | 0 |
| Nov 25, 2025 | CAPPS, KATHLEEN S. | See Remarks | Common Stock | Acquisition | 3,163 | 0 |
| Nov 25, 2025 | KIEFFER, TARA LYNN | Chief Product Strategy Officer | Stock Option (right to buy) | Acquisition | 100,000 | 0 |
| Nov 25, 2025 | ROTTINGHAUS, SCOTT T. | Chief Medical Officer | Stock Option (right to buy) | Acquisition | 110,000 | 0 |
| Nov 25, 2025 | CAPPS, KATHLEEN S. | See Remarks | Stock Option (right to buy) | Acquisition | 6,325 | 0 |
| Nov 25, 2025 | TROUT, HARRY R. III | See Remarks | Stock Option (right to buy) | Acquisition | 12,925 | 0 |
| Nov 25, 2025 | TROUT, HARRY R. III | See Remarks | Common Stock | Acquisition | 6,463 | 0 |
| Nov 25, 2025 | OR, YAT SUN | Chief Scientific Officer | Stock Option (right to buy) | Acquisition | 110,000 | 0 |